Published in Haemophilia on November 01, 1999
Treatment of hemophilia: a review of current advances and ongoing issues. J Blood Med (2010) 1.07
Diagnostic and therapeutic challenges of intracranial hemorrhage in neonates with congenital hemophilia: a case report and review. Ochsner J (2012) 0.82
A survey of the management of newborns with severe hemophilia in Canada. Paediatr Child Health (2013) 0.75
Hemophilia during pregnancy. Can Fam Physician (2003) 0.75
Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost (2001) 3.13
The emperor's new clothes: the OSCE reassessed. Acad Med (1996) 2.27
Psychosocial factors are associated with health care seeking rather than diagnosis in irritable bowel syndrome. Gastroenterology (1990) 1.92
Intracranial and extracranial hemorrhages in newborns with hemophilia: a review of the literature. J Pediatr Hematol Oncol (1999) 1.88
Vehicle-Related Hydrocarbon Source Compositions from Ambient Data: The GRACE/SAFER Method. Environ Sci Technol (1994) 1.59
Gender-specific differences in family practice graduates. J Fam Pract (1986) 1.37
Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors. Thromb Haemost (1998) 1.35
Gender differences in Manning criteria in the irritable bowel syndrome. Gastroenterology (1991) 1.34
Factor IX inhibitors and anaphylaxis in hemophilia B. J Pediatr Hematol Oncol (1997) 1.34
Automated dithionite test for rapid, inexpensive detection of hemoglobin S and non-S sickling hemoglobinopathies. Clin Chem (1971) 1.24
Evaluation and implementation of public health registries. Public Health Rep (1991) 1.20
Inhibitors in factor IX deficiency a report of the ISTH-SSC international FIX inhibitor registry (1997-2006). Haemophilia (2009) 1.19
Iron deficiency with and without anemia in infants and children. Am J Dis Child (1974) 1.19
Efficacy of prothrombin-complex concentrates in hemophiliacs with antibodies to factor VIII: a multicenter therapeutic trial. N Engl J Med (1980) 1.16
Rewards and incentives for nonsalaried clinical faculty who teach medical students. J Gen Intern Med (1999) 1.12
Anaphylactic response to factor IX replacement therapy in haemophilia B patients: complete gene deletions confer the highest risk. Haemophilia (1999) 1.08
Dithionite tube test--a rapid, inexpensive technique for the detection of hemoglobin S and non-S sickling hemoglobin. Clin Chem (1971) 1.08
Idiopathic thrombocytopenic purpura in childhood. J Pediatr (1966) 1.07
B-domain deleted recombinant factor VIII preparations are bioequivalent to a monoclonal antibody purified plasma-derived factor VIII concentrate: a randomized, three-way crossover study. Haemophilia (2005) 1.07
Community partnerships: educational linkages to increase the number of primary care practitioners. Acad Med (1993) 1.06
Low CD4+ counts in a study of transfusion safety. The Transfusion Safety Study Group. N Engl J Med (1993) 1.02
Development of anaphylactic shock in haemophilia B patients with inhibitors. Blood Coagul Fibrinolysis (1998) 0.98
Variability in serial CD4 counts and relation to progression of HIV-I infection to AIDS in haemophilic patients. Transfusion Safety Study Group. BMJ (1992) 0.98
Oral urea and the prophylactic treatment of sickle cell disease--a preliminary report. Am J Med Sci (1971) 0.98
Idiopathic thrombocytopenic purpura in children. Semin Thromb Hemost (1977) 0.97
Anti-s hemolytic disease: a case report. Transfusion (1967) 0.97
Neurological complications of sickle cell anemia. Am J Pediatr Hematol Oncol (1982) 0.96
Preventive medicine: physician practices, beliefs, and perceived barriers for implementation. Fam Med (1987) 0.95
The use of porcine factor VIII concentrate (Hyate:C) in the treatment of patients with inhibitor antibodies to factor VIII. A multicenter US experience. Arch Intern Med (1989) 0.94
DDAVP: does the drug have a direct effect on the vessel wall? Thromb Res (1983) 0.94
The incidence of development of irregular red cell antibodies in patients with sickle cell anemia. Transfusion (1986) 0.92
Sickle cell crisis terminated by intravenous urea in sugar solutions--a preliminary report. Am J Med Sci (1971) 0.91
Idiopathic thrombocytopenic purpura in children. The case for management without corticosteroids. Am J Pediatr Hematol Oncol (1984) 0.90
Intravenous gamma globulin treatment for chronic idiopathic thrombocytopenic purpura in children. Am J Med (1984) 0.89
Congenital disorders affecting platelets. Semin Thromb Hemost (1977) 0.89
A prophylactic transfusion program for children with sickle cell anemia complicated by CNS infarction. Am J Hematol (1976) 0.89
Nutrition and society. JAMA (1971) 0.88
The overall effectiveness of prophylaxis in severe haemophilia. Haemophilia (2003) 0.86
A packaged workshop for teaching critical reading of the medical literature. Med Teach (1988) 0.86
Open heart surgery in a hemophiliac patient. Hematologic management. Am J Dis Child (1974) 0.85
Aneurysm of the internal carotid artery presenting as a peritonsillar abscess. J Laryngol Otol (1974) 0.85
Hemophilia A in chromosomal female subjects. J Pediatr (1969) 0.85
Multidisciplinary education outcomes of the W.K. Kellogg Community Partnerships and Health Professions Education initiative. Acad Med (1998) 0.85
Preoperative exchange transfusion in sickle cell anemia. J Pediatr Surg (1981) 0.85
Pharmacokinetics of von Willebrand factor and factor VIIIC in patients with severe von Willebrand disease (type 3 VWD): estimation of the rate of factor VIIIC synthesis. Cooperative Study Groups. Br J Haematol (1996) 0.84
Recent evolution of clotting factor concentrates for hemophilia A and B. Transfusion Practices Committee. Transfusion (1993) 0.84
Inhibition of CD40 ligand (CD154) in the treatment of factor VIII inhibitors. Haematologica (2000) 0.83
The May-Hegglin anomaly: platelet function, ultrastructure and chromosome studies. Blood (1968) 0.83
Childhood idiopathic thrombocytopenic purpura. Am J Dis Child (1977) 0.83
Structural physiology of the human spleen. Am J Pediatr Hematol Oncol (1979) 0.83
DDAVP: a useful alternative to blood components in moderate hemophilia A and von Willebrand disease. J Pediatr (1983) 0.83
Erythropoiesis in sickle cell anaemia during acute infection and crisis. Scand J Haematol (1979) 0.82
Hematological parameters and marrow in vitro colony forming cells in acute lymphoblastic leukemia after cessation of treatment. Nihon Ketsueki Gakkai Zasshi (1980) 0.82
Autoplex versus proplex: a controlled, double-blind study of effectiveness in acute hemarthroses in hemophiliacs with inhibitors to factor VIII. Blood (1983) 0.82
Phenotypic change of acute monocytic leukemia to acute lymphoblastic leukemia on therapy. Am J Pediatr Hematol Oncol (1983) 0.82
Evaluation of a faculty development program for family physicians. Med Teach (1988) 0.82
Desmopressin and thrombosis. Lancet (1989) 0.81
Immune tolerance induction in the treatment of paediatric haemophilia A patients with factor VIII inhibitors. Haemophilia (2000) 0.81
Platelet-vessel-wall interactions: experiences with von Willebrand platelets. Ann N Y Acad Sci (1981) 0.81
Safety and efficacy of monoclonal antibody purified factor IX concentrate in previously untreated patients with hemophilia B. Thromb Haemost (1996) 0.81
Ethanol lock therapy for the treatment of catheter-related infections in haemophilia patients. Haemophilia (2009) 0.80
Characterization of autoantibodies against the platelet glycoprotein antigens IIb/IIIa in childhood idiopathic thrombocytopenia purpura. Am J Hematol (1995) 0.80
HIV and hemophilia. J Thromb Haemost (2007) 0.80
A comparison of two antismoking interventions among pregnant women in eleven private primary care practices. J Fam Pract (1989) 0.80
Severe factor VIII and factor IX deficiency in females. Am J Med (1978) 0.79
The human spleen as revealed by scanning electron microscopy. Am J Hematol (1976) 0.79
Safety and immunogenicity of subcutaneous hepatitis A vaccine in children with haemophilia. Haemophilia (2000) 0.79
Arteriovenous shunts in the human spleen. Am J Hematol (1976) 0.79
A course component to teach interviewing skills in informing and motivating patients. J Med Educ (1988) 0.78
Breast and testicular self-examination in primary care. Am J Prev Med (1988) 0.78
Sickledex test for hemoglobin S. A critique. JAMA (1971) 0.78
Nutrition and social correlates in iron deficiency anemia. Am J Clin Nutr (1978) 0.78
Evaluating the impact on public policy of foundation-sponsored programs in the health professions. Eval Health Prof (1999) 0.78
Acute idiopathic thrombocytopenic purpura--management in childhood. Blood (1997) 0.78
Transmission of human immunodeficiency virus type 1 by dry-heated clotting factor concentrates. Transfusion Safety Study Group. Vox Sang (1990) 0.78
The detection of sickle cell hemoglobin in large human populations by an automated technique. Mil Med (1972) 0.77
Familial warfarin resistance in a black child. Am J Pediatr Hematol Oncol (1986) 0.77
Initial clinical experience with a new pasteurized monoclonal antibody purified factor VIIIC. Semin Hematol (1990) 0.76
The safety and efficacy of B-domain deleted recombinant factor VIII concentrates in patients with severe haemophilia A: an update. Haemophilia (2005) 0.76
The transformation of laryngeal leucoplakia to cancer. J Laryngol Otol (1979) 0.76
Assessing the impact of faculty development programs in medical education. J Med Educ (1984) 0.75
The practical problem of inconsistent data sets: improving precision and accuracy for telephone surveys and medical record data. Fam Pract Res J (1994) 0.75
Congenital thrombocytopenias. Curr Opin Hematol (1995) 0.75
Principles to guide AHC-community partnerships. Acad Med (2001) 0.75
Lack of inhibitor to monoclonal-antibody purified factor VIII concentrate. Lancet (1990) 0.75
Macroglobulinemia in a child with acute leukemia. Blood (1974) 0.75
Passive antibody to hepatitis A virus in US haemophiliacs. Lancet (1993) 0.75
Bone changes in sickle cell disease. Paleopathol Newsl (1975) 0.75
The effect of 5-hydroxytryptamine and epinephrine on newborn platelets. Eur J Pediatr (1978) 0.75
Antibody nature of an AHG (factor 8) inhibitor. J Pediatr (1968) 0.75
Acute lymphoid leukemia. Pediatr Ann (1978) 0.75
IMFRA (intermittent intrathecal methotrexate and fractional radiation) plus chemotherapy in childhood leukemia. Am J Hematol (1976) 0.75
Evaluation of oral urea in the management of sickle cell anemia. Adv Exp Med Biol (1972) 0.75
Repetitive low-dose radiation therapy for acute stem-cell leukemia. Int J Radiat Oncol Biol Phys (1977) 0.75
Festschrift in homor of Wolf W. Zuelzer, M.D. Am J Hematol (1976) 0.75
Immunoglobulins in idiopathic thrombocytopenic purpura in childhood. Acta Haematol (1976) 0.75
Viral safety and clotting factor concentrates. Thromb Haemost (1994) 0.75